vs
AGENUS INC（AGEN）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是AGENUS INC的1.7倍（$57.1M vs $34.2M），REGIS CORP净利率更高（0.8% vs -31.0%，领先31.8%），AGENUS INC同比增速更快（27.5% vs 22.3%），过去两年AGENUS INC的营收复合增速更高（10.5% vs 7.8%）
Agenus Inc.是一家总部位于美国马萨诸塞州列克星敦的生物技术公司，核心业务聚焦免疫治疗领域，尤其专注于利用人体免疫系统控制或治愈癌症的肿瘤免疫治疗。公司目前正在研发检查点调节剂、个性化抗癌疫苗，以及可适配多种疫苗的免疫佐剂，其中检查点调节剂作为当前进展迅速的方向，早期产品已为患者带来突破性临床获益。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
AGEN vs RGS — 直观对比
营收规模更大
RGS
是对方的1.7倍
$34.2M
营收增速更快
AGEN
高出5.2%
22.3%
净利率更高
RGS
高出31.8%
-31.0%
两年增速更快
AGEN
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $34.2M | $57.1M |
| 净利润 | $-10.6M | $456.0K |
| 毛利率 | — | — |
| 营业利润率 | 42.1% | 10.8% |
| 净利率 | -31.0% | 0.8% |
| 营收同比 | 27.5% | 22.3% |
| 净利润同比 | 77.3% | -94.0% |
| 每股收益（稀释后） | $0.09 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGENRGS
| Q4 25 | $34.2M | $57.1M | ||
| Q3 25 | $30.2M | $59.0M | ||
| Q2 25 | $25.7M | $60.4M | ||
| Q1 25 | $24.1M | $57.0M | ||
| Q4 24 | $26.8M | $46.7M | ||
| Q3 24 | $25.1M | $46.1M | ||
| Q2 24 | $23.5M | $49.4M | ||
| Q1 24 | $28.0M | $49.2M |
净利润AGENRGS
| Q4 25 | $-10.6M | $456.0K | ||
| Q3 25 | $63.9M | $1.4M | ||
| Q2 25 | $-30.0M | $116.5M | ||
| Q1 25 | $-26.4M | $250.0K | ||
| Q4 24 | $-46.8M | $7.6M | ||
| Q3 24 | $-67.2M | $-853.0K | ||
| Q2 24 | $-54.8M | $91.2M | ||
| Q1 24 | $-63.5M | $-2.3M |
毛利率AGENRGS
| Q4 25 | — | — | ||
| Q3 25 | 97.9% | — | ||
| Q2 25 | 99.1% | — | ||
| Q1 25 | 99.4% | — | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 99.5% | — | ||
| Q1 24 | 99.6% | — |
营业利润率AGENRGS
| Q4 25 | 42.1% | 10.8% | ||
| Q3 25 | -15.0% | 10.0% | ||
| Q2 25 | -65.0% | 12.1% | ||
| Q1 25 | -55.3% | 8.8% | ||
| Q4 24 | -96.5% | 11.8% | ||
| Q3 24 | -125.5% | 4.6% | ||
| Q2 24 | -128.4% | — | ||
| Q1 24 | -117.4% | 8.3% |
净利率AGENRGS
| Q4 25 | -31.0% | 0.8% | ||
| Q3 25 | 211.4% | 2.3% | ||
| Q2 25 | -116.8% | 192.9% | ||
| Q1 25 | -109.6% | 0.4% | ||
| Q4 24 | -174.4% | 16.4% | ||
| Q3 24 | -267.7% | -1.9% | ||
| Q2 24 | -233.1% | 184.7% | ||
| Q1 24 | -226.6% | -4.7% |
每股收益（稀释后）AGENRGS
| Q4 25 | $0.09 | $0.16 | ||
| Q3 25 | $1.94 | $0.49 | ||
| Q2 25 | $-1.00 | $43.67 | ||
| Q1 25 | $-1.03 | $0.08 | ||
| Q4 24 | $-1.95 | $2.71 | ||
| Q3 24 | $-3.08 | $-0.36 | ||
| Q2 24 | $-2.52 | $38.40 | ||
| Q1 24 | $-3.04 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $18.4M |
| 总债务越低越好 | $44.7M | $113.3M |
| 股东权益账面价值 | $-271.1M | $188.7M |
| 总资产 | $226.8M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资AGENRGS
| Q4 25 | $3.0M | $18.4M | ||
| Q3 25 | $3.5M | $16.6M | ||
| Q2 25 | $9.5M | $17.0M | ||
| Q1 25 | $18.5M | $13.3M | ||
| Q4 24 | $40.4M | $10.2M | ||
| Q3 24 | $44.8M | $6.3M | ||
| Q2 24 | $93.7M | $10.1M | ||
| Q1 24 | $52.9M | $5.9M |
总债务AGENRGS
| Q4 25 | $44.7M | $113.3M | ||
| Q3 25 | $34.2M | $111.3M | ||
| Q2 25 | $33.9M | $110.8M | ||
| Q1 25 | $33.6M | $112.0M | ||
| Q4 24 | $33.2M | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益AGENRGS
| Q4 25 | $-271.1M | $188.7M | ||
| Q3 25 | $-274.1M | $187.6M | ||
| Q2 25 | $-354.6M | $185.6M | ||
| Q1 25 | $-341.8M | $68.6M | ||
| Q4 24 | $-326.4M | $66.7M | ||
| Q3 24 | $-292.3M | $56.4M | ||
| Q2 24 | $-241.3M | $56.8M | ||
| Q1 24 | $-201.4M | $-35.8M |
总资产AGENRGS
| Q4 25 | $226.8M | $588.3M | ||
| Q3 25 | $233.9M | $592.1M | ||
| Q2 25 | $185.2M | $599.0M | ||
| Q1 25 | $200.2M | $511.2M | ||
| Q4 24 | $226.3M | $530.1M | ||
| Q3 24 | $238.5M | $508.9M | ||
| Q2 24 | $292.4M | $530.5M | ||
| Q1 24 | $256.6M | $543.7M |
负债/权益比AGENRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-16.6M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | — | $891.0K |
| 自由现金流率自由现金流/营收 | — | 1.6% |
| 资本支出强度资本支出/营收 | 0.0% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | — | $14.9M |
8季度趋势，按日历期对齐
经营现金流AGENRGS
| Q4 25 | $-16.6M | $1.7M | ||
| Q3 25 | $-14.7M | $2.3M | ||
| Q2 25 | $-20.2M | $6.8M | ||
| Q1 25 | $-25.6M | $6.2M | ||
| Q4 24 | $-28.7M | $2.1M | ||
| Q3 24 | $-53.3M | $-1.3M | ||
| Q2 24 | $-38.2M | $5.1M | ||
| Q1 24 | $-38.2M | $-277.0K |
自由现金流AGENRGS
| Q4 25 | — | $891.0K | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | $-20.2M | $6.2M | ||
| Q1 25 | $-25.6M | $5.9M | ||
| Q4 24 | $-28.7M | $1.7M | ||
| Q3 24 | $-53.3M | $-1.4M | ||
| Q2 24 | $-38.6M | $5.1M | ||
| Q1 24 | $-38.2M | $-326.0K |
自由现金流率AGENRGS
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | -78.7% | 10.3% | ||
| Q1 25 | -106.5% | 10.3% | ||
| Q4 24 | -107.0% | 3.6% | ||
| Q3 24 | -212.2% | -3.0% | ||
| Q2 24 | -164.4% | 10.3% | ||
| Q1 24 | -136.5% | -0.7% |
资本支出强度AGENRGS
| Q4 25 | 0.0% | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.3% | 0.9% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 2.0% | 0.0% | ||
| Q1 24 | 0.1% | 0.1% |
现金转化率AGENRGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | -0.23× | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
